The feasibility of wavelength dispersive X-ray fluorescence spectrometry for the assessment of lead concentration in animal bone powder by Brito, José A. A. de et al.
Journal Name 
Cite this: DOI: 10.1039/c0xx00000x 
www.rsc.org/xxxxxx 
Dynamic Article Links ► 
ARTICLE TYPE 
 
This journal is © The Royal Society of Chemistry [year] [journal], [year], [vol], 00–00  |  1 
The feasibility of wavelength dispersive X-ray fluorescence spectrometry 
for the assessment of lead concentration in animal bone powder 
José A. A. Brito,* Inês I. B. Cavaleiro, Tânia  A. P. Fernandes and Luísa M. L. Gonçalves 
Received (in XXX, XXX) Xth XXXXXXXXX 20XX, Accepted Xth XXXXXXXXX 20XX 
DOI: 10.1039/b000000x 5 
This work demonstrates the feasibility of wavelength 
dispersive X-ray fluorescence for the assessment of lead in 
animal bone powder. When applied to real bone samples, this 
analytical procedure produced results compatible with 
current knowledge of lead metabolism, emerging as an 10 
important tool in the investigation of relevant issues in Public 
Health.  
Introduction  
Studies have confirmed that levels of lead (Pb) exposure lower 
than the present acceptable cutoff points are associated with 15 
increased mortality.1 Metabolic modelling of Pb is important to 
define guidelines for prevention in occupational and 
environmental exposure to Pb. These models, were developed 
before large epidemiological data sets including bone Pb were 
available, and do not reproduce well those data.2 Surveys 20 
conducted in occupationally exposed populations provided 
evidence contrary to assumptions in such models,3 and the call 
has been issued that these models should be revised with a view 
to adjusting them to account for kinetic rates varying with age 
and probably also with exposure level.2,3 25 
 Lead exposure is also associated with reduced bone mass and 
quality, which may predispose to osteoporosis,4 a disease with 
clinical and public health importance due to the associated 
fractures. At present, the diagnosis of osteoporosis is centered on 
the assessment of bone mineral density (BMD), typically by 30 
single or dual X-ray absorptiometry (DXA).5 However, DXA 
alone is not optimal to detect people at high risk of fracture and 
information on validated risk factors other than BMD is 
necessary; among those, indices of bone turnover have been 
identified as factors that can enhance the predictive value of 35 
BMD.6,7  
 The relationships between the concentration of Pb in bone and 
the rate of Pb removal from bone cannot be fully addressed by in 
vivo bone Pb surveys, because the epidemiological data thus 
collected would convey information on the co-variation between 40 
those biological variables but not on a possible causal 
relationship between them. Furthermore, nutritional and 
toxicological studies carried out with single elements might 
project an inconclusive picture unless the levels of interacting 
elements in biological tissues are known.8 In sum, it is necessary 45 
to establish the relative importance of Pb exposure, and its 
interactions with other elements, on bone formation and 
resorption, as well as the degree to which changes in turnover 
may account for observed rates of Pb removal from bone tissue.3 
Cleary the best means for investigating these relationships is to 50 
use an animal model, and the ability to perform multi-element 
analysis on small samples is an important advantage to 
accomplish that goal.  
 Previous research has shown that multi-element energy 
dispersive X-ray fluorescence determinations in pelletized 55 
samples of human hard and soft tissues are feasible and useful 
when assessing the concentration of an element in an internal 
organ (eg, bone), based on its concentration in more accessible 
tissues (eg, hair).9 This, however, requires considerable sample 
preparation time in cases of high sample throughput and the 60 
application of considerable force to compact heterogeneous 
powder into a pellet sample, which may not be possible in all 
labs. This paper discusses the feasibility of a wavelength 
dispersive X-ray fluorescence technique for the rapid assessment 
of Pb concentrations in powder samples of small animal bones. 65 
The focus is on the characteristics for consideration in the 
validation of an analytical procedure using a commercial 4 kW 
X-ray fluorescence spectrometer for the purpose of determining 
Pb in animal bone powder.  
 The procedures described here are included in a larger research 70 
project which aims are: (i) to assess the impact of exposure to Pb 
on biochemical markers of bone formation and resorption, (ii) to 
assess the magnitude of Pb uptake and its interactions with other 
elements in cortical and trabecular bone in healthy animals and 
animals with altered bone turnover, and (iii) to investigate the 75 
elemental concentration profiles in those tissues as tissue 
predictors for osteoporosis. To the best of the authors’ 
knowledge, this is the first attempt to address such relationships 
using this X-ray fluorescence technique.  
 The authors declare that the animal study included in this 80 
research project was approved by the Ethics Committee of the 
Instituto Superior de Ciências da Saúde Egas Moniz and 
conducted in accordance with the Portuguese Law.   
Materials and methods 
Semi-quantitative X-ray fluorescence determinations  85 
Prior to system calibration, semi-quantitative X-ray fluorescence 
measurements were performed on cortical (femora) and 
trabecular (vertebrae) bone samples from 48 adult female Wistar 
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rats, with the purpose to define a suitable matrix for bone powder 
samples and a concentration range for Pb in calibration standards. 
The animals were selected from 3 experimental groups, who had 
been exposed to known concentrations of Pb in drinking water 
(50, 200 and 500 ppm) since the age of 6 months, and from one 5 
age-matched non-exposed group. Exposure lasted for 6 months 
and all animals were euthanized by inhalation of 70% CO2. After 
excision, fresh femora and lumbar vertebrae were prepared in the 
following sequence: 24-hour ultrasound bath in distilled water, 
which helped removing most of the remaining soft tissue at bone 10 
surface, using a surgical scalpel with stainless steel blade; 24-
hour freeze drying, with a multipurpose ice condenser 
(ModulyoD-230, Thermo Savant) operated at a nominal 
temperature of -50 C, was used to remove any excess water; and 
grinding in an agate mortar to reduce the samples to a fine 15 
powder.  
 The semi-quantitative measurements of animal bone powder 
were performed with a 4 kW commercial wavelength dispersive 
X-ray fluorescence spectrometer (Bruker S4 Pioneer), using a Rh 
X-ray tube with a 75 μm Be end window and a 34 mm diameter 20 
collimator mask. Measurements were performed with the 
analytical parameters described in Table 1, in helium mode and 
using high-density polyethylene X-ray fluorescence sample cups 
with 35.8 mm diameter assembled with a 4 µm prolene film to 
support the bone sample. The polyethylene cup was placed in 25 
steel sample cup holders with an opening diameter of 34 mm. 
Bone mass was in the range 1 to 2.2 g for vertebrae and 1 to 1.5 g 
for femora, which produced samples of bone powder with heights 
between 1 and 2 mm.  
 In order to insure reliable matrix corrections, necessary for the 30 
closeness of calculated and real Pb concentrations, calcium 
carbonate (CaCO3) was investigated as a suitable matrix for bone 
powder samples. This is based on the fact that dry bone is 
composed mainly by calcium, a major constituent of bone 
hydroxyapatite crystals [Ca10(PO4)6(OH)2], and by a smaller but 35 
non-negligible organic phase containing essentially light elements 
(C, H and O). Conceivably, the effective atomic number (Zeff) of 
dry bone powder is slightly lower than that of hydroxyapatite (Zeff 
= 11.4), and therefore a lighter calcium compound such as CaCO3 
(Zeff = 10) seemed to ensure effective matrix corrections in the 40 
measurement of bone powder samples. This was confirmed 
through the evaluation of spectra produced by the X-ray 
fluorescence measurements of femora and vertebrae bone 
samples from 48 animals, in which a CaCO3 matrix was assumed 
after mass correction. This evaluation resulted in estimated ratios 45 
of theoretical to measured intensities in the range 0.4 to 0.6, for 
Compton scattering, and between 0.9 and 1.1, for Rayleigh 
scattering. Since Compton scattering is more important in light 
matrices, while Rayleigh scattering is more important in heavy 
matrices, the fact that Rayleigh ratios are reasonably close to 1 50 
supports the hypothesis that CaCO3 appropriately simulates a 
bone sample matrix and the closeness of the calculated and real 
Pb concentrations.  
 An estimate of a suitable concentration range for Pb in 
calibration standards was made based on the same semi-55 
quantitative X-ray fluorescence measurements. After mass 
correction, the measured bone Pb concentrations were in the 
ranges 0 to 250 ppm, in femora, and 0 to 360 ppm, in vertebrae,  
Table 1 Analytical parameters in X-ray fluorescence measurementsa,b 
Pb x-
ray 
Rate/ kV 
mA-1 
Filter  Collimator/ Crystal  Detector 
Pb Lα1  60/50 None 0.46 LiF200 SC 
Pb Lβ1  60/50 None 0.46 LiF200 SC 
 
a LiF200: lithium fluoride. 
b SC: scintillation counter. 
 60 
which were used to define the concentrations of Pb in calibration 
standards in the range 0 to 400 ppm.  
Standard preparation and system calibration 
For the calibration of the X-ray fluorescence system a set of 9 
synthetic standards were prepared in triplicate by doping calcium 65 
carbonate with known amounts of lead (II) acetate 
(C4H6O4Pb.3H2O), according to the following description: 5mL 
of Milli-Q water and known volumes of a lead (II) acetate 
solution (100 ppm) were added to 3g of CaCO3; after 
homogenizing with magnetic stirring, all standards were dried 70 
overnight in an oven at 50ºC and then analysed by X-ray 
fluorescence. The Pb concentrations in standards were: 0, 2, 10, 
25, 50, 100, 200, 300 and 400 ppm. Chemicals used in this study 
were of high analytical grade (> 99%) and were purchased from 
Sigma-Aldrich and Scharlau Chemie. Previously to its use, all 75 
glassware was washed, kept overnight in EDTA solution (0.1M) 
and rinsed with Milli-Q water.  
 For calibration purposes, the measurement mode and analytical 
parameters were as described for the semi-quantitative 
measurements of bone powder (Table 1). Polyethylene cups and 80 
steel cup holders of the type utilized in those measurements were 
used to irradiate the CaC03 standards. In addition, the net 
intensities were calculated from peak and background 
measurements on fixed positions, with sample rotation of 0.5 
rev/s: for the Pb Lα1 X-ray, peak intensity was measured at a 2 85 
angle of 33.948 while background intensity was measured at 2 
angles of 32.924 and 35.007; for the Pb Lβ1 X-ray, peak 
intensity was measured at a 2 angle of 28.263 with background 
intensity measured at 2 angles of 27.384 and 29.366. The 
measurement times were fixed based on measuring scans on 90 
multiple standard samples, in order to insure a counting statistical 
error of not more than 5% for a 3 criterion. This was 
accomplished with measurement times set at 180 s. 
 Since the concentration of Pb in samples of animal bone 
powder can be estimated based on the measured intensity of 95 
either the Pb Lα1 or the Pb Lβ1 X-rays, the characteristics for 
consideration in the validation of the analytical procedure based 
on each of these X-rays are discussed separately. 
Results  
Specificity of the method 100 
The specificity of the method was investigated through scans of a 
CaCO3 standard sample doped with 300 ppm Pb (data not shown) 
and through semi-quantitative measurements of a femur sample 
from an animal exposed to 500 ppm, using the measurement 
protocol described above (Table 1). The obtained spectra showed 105 
that the Pb Lα1 and Pb Lβ1 peaks are well separated from each 
other and from peaks of other elements in bone (Figure 1), with 
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Figure 1a)  Spectrum of femur sample from one animal exposed to 500 ppm (x-rays reflected by LiF200 crystal) 
 
 
Figure 1b) Spectrum of femur sample from one animal exposed to 500 ppm (x-rays reflected by PET crystal) 5 
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no evidence of peak overlaps, which is taken here to demonstrate 
the method specificity. 
Linearity and range 
Linear regression models based on the Pb Lα1 and Pb Lβ1 X-ray 
intensities were fit to the spectral data collected from the 5 
measurement of 27 standards with Pb concentrations described 
above. The fit was obtained using the net intensity model, since 
no significant peak overlapping was detected. Matrix absorption 
effects were corrected using the variable alphas method.  
 Regression methods did not discard the null hypothesis of a 10 
strong linear association between Pb concentrations and 
intensities, as suggested by visual inspection of the regression 
lines depicted in Figure 2. First, correlation coefficients in excess 
of 0.999 were estimated for both Pb lines. Second, inclusion of a 
quadratic term representing the squared concentrations in the 15 
model did not result in a significant improvement in the models 
ability to describe the relationship between intensities and 
concentrations, as the F statistic showed no significant change    
(p > 0.05). Therefore, the null hypothesis of appropriateness of 
the linear regression model should not be rejected. In addition, 20 
residual analysis did not detect any gross violation of the 
homoscedasticity assumption for regression analysis. In these 
conditions, all calculations are based on a full calibration model 
estimated with the set of 27 standards (Table 2). 
 25 
Figure 2 Calibration lines obtained for the Pb Lα1 (solid line) and Pb Lβ1 
peaks (dashed line). 
 
 
 30 
Table 2 Calibration models estimated from measurements of 27 standards 
Pb x-ray Intercept/kcps Slope/kcps per ppm r RMSa 
Pb Lα1 0.00344 ± 0.00202 0.00402 ± 0.00001  0.9999 6.2E-5 
 Pb Lβ1 0.00537 ± 0.00179 0.00364 ± 0.00001 0.9999 4.9E-5 
 
a RMS: Residual Mean Square. 
 
Detection and quantitation limits 
For each Pb peak, the detection limit (DL) of the method was 
determined as DL = 3.3/S, where  is the standard error of the 35 
calibration line intercept and S is the slope of the same line 
(Table 2). The detection limits thus estimated were 1.66 and 1.62 
ppm for the analytical models based on the Pb Lα1 and the Pb Lβ1 
X-ray, respectively. The quantitation limit (QL) was estimated as 
QL = 10/S, with  and S defined as above, which resulted in QL 40 
of 5.0 and 4.9 ppm, for the Pb Lα1 and the Pb Lβ1 analytical 
models, respectively. 
Precision and accuracy 
Intra-assay precision was assessed at 3 concentration levels (10, 
150 and 250 ppm) for both analytical models, as the coefficient of 45 
variation (CV) of 12 repeat measurements. The following CV 
values for Pb Lα1 and the Pb Lβ1 models, respectively, were 
estimated: at 10 ppm, 5.0% and 7.6%; at 150 ppm, 0.4% and 
0.5%; at 250 ppm, 0.3% and 0.3%.   
 The accuracy of the proposed method was first assessed as the 50 
percent recovery determined by the matrix spike method applied 
to real bone samples. For that purpose, we have doped 3 femur 
samples with known amounts of lead (50 ppm) and performed 3 
replicate measurements of each of the spiked samples with the 
proposed method for each of the Pb peaks. The Pb concentrations 55 
in the non-spiked samples were 0, 40 and 110 ppm. For the 
calibration model based on the Pb Lβ1 X-ray, the obtained percent 
recoveries were in the range 87.0 – 106.5 %, with mean value  
97.2 ± 6.2 %, whereas for the Pb Lα1 X-ray, percent recoveries 
ranged from 104.4 – 114.3%, with mean value 109.5 ± 3.0%, 60 
which are well inside the acceptable range.10 Moreover, the 
accuracy of method was also investigated through to the 
measurement of the NYS RMs 05-02 through 04 with certified 
values of 16.1 ± 0.3 (NYS RM 05-02), 13.2 ± 0.3 (NYS RM 05-
03) and 31.5 ± 0.7 (NYS RM 05-04) μg g−1 Pb.11 For the NYS 65 
RM 05-02 through 04, respectively, the results obtained were 
15.6 ± 1.5, 11.3 ± 1.0 and 31.3 ± 1.2 ppm (Pb Lβ1 X-ray) and 15.3 
± 1.0, 12.0 ± 0.5 and 31.6 ± 1.0 ppm (Pb Lα1 X-ray), showing 
good agreement with certified values. 
 The method was applied to femora and vertebrae powder 70 
obtained from animals exposed to increasing levels of Pb through 
drinking water. Regardless of the analytical model considered to 
estimate bone Pb concentrations, increasing bone Pb 
concentrations were observed with increasing exposure, which is 
consistent with current knowledge of Pb metabolism.12 In fact, 75 
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non-parametric comparisons between the 3 exposed groups have 
identified significant differences between the groups (p < 0.001), 
regardless of the bone site and analytical model (Figure 3). 
Moreover, higher Pb concentrations were observed in vertebrae 
than in femora, which is also expected since it reflects the higher 5 
metabolic activity of trabecular bone.13    
Conclusions 
These results show that the proposed analytical procedures based 
in wavelength dispersive X-ray fluorescence spectrometry 
possess the necessary degree of linearity, sensitivity, precision 10 
and accuracy required for the rapid assessment of Pb 
concentrations in powders of different types of bone of exposed 
animals. At this stage, a few points are worth mentioning.  
 First, the uncertainty of the measurement results could be 
further reduced through the combination of the individual X-ray 15 
estimates of Pb concentrations and uncertainties. In effect, 
following the method implemented in in vivo assessments of Pb 
in human bone, for example, the inverse variance weighted mean 
of the concentrations estimated by the Pb Lα1 and the Pb Lβ1 
models could have been reported as measurement result, which 20 
uncertainty is less than that of the individual estimates of Pb 
concentrations.14 This can be particularly useful in the assessment 
of low bone Pb concentrations which quite often show statistical 
errors higher than 5%. Second, doping powder samples of 
excised animal bones with known amounts of Pb does not seem 25 
to be a process capable of reproducing the routes of entrance of 
Pb in bones of a living animal. In other words, it is not 
immediately clear how the process of diffusion from the doping 
solution to the bone powder would model the incorporation of Pb 
in the bone matrix during bone formation in a living animal. 30 
Notwithstanding these concerns, the matrix spike method applied 
to samples of animal bone has produced acceptable percent 
recoveries for the Pb Lα1 and the Pb Lβ1 analytical models. 
 Although there are bone-based Standard Reference Materials 
(SRM) with certified lead concentrations, these SRMs differ 35 
 
Figure 3 Bone Pb concentrations in femora and vertebrae of animals 
exposed to increasing Pb levels in drinking water: group 2 (50 ppm), 
group 3 (200 ppm), group 4 (500 ppm) 
strongly in appearance and composition, with either very high or 40 
negligible organic content,11 which are far from the physical 
attributes of the dry bones analysed in this work. Three of the 
four candidate ground bone reference materials produced from 
lead-dosed bovine and caprine sources and characterized by inter-
laboratory study were used in this work to assess the accuracy of 45 
the method,11 despite the fact that marked interspecies differences 
with regard to bone composition and bone density have been 
reported in another study, which concluded that data derived from 
such standard reference materials should also be considered with 
utmost care.15 In any case, the results obtained in this work with 50 
the measurement of NYS RM 05-02 through 04 show good 
agreement with the consensus and certified values in the 
interlaboratory study, despite the differences between the animal 
sources and the animal model used here. 
 Finally, the results obtained with the application of the method 55 
to animal bone powder samples, which are in close agreement 
with current knowledge of lead metabolism, particularly in what 
concerns the expected trends with exposure level and the 
accumulation patterns in different bone tissues, are reassuring.  
 Altogether, this demonstrates the feasibility of wavelength 60 
dispersive X-ray fluorescence spectrometry for the assessment of 
Pb concentration in animal bone powder, an important asset to 
the investigation of the role of this element in the aetiology of 
osteoporosis.  
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